Literature DB >> 2681795

Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.

A D Kaluzny1, T Ricketts, R Warnecke, L Ford, J Morrissey, D Gillings, E J Sondik, H Ozer, J Goldman.   

Abstract

Current theories of organizational performance are used to guide researchers at the Health Services Research Center of the University of North Carolina at Chapel Hill and the University of Illinois Survey Research Laboratory in the evaluation of the National Cancer Institute's Community Clinical Oncology Program (CCOP) and to derive policy options to enhance program operations. CCOP represents an innovative mechanism designed to improve the accrual of patients to phase III clinical trials, involve community-based oncologists in clinical research, and potentially to disseminate new information on the state-of-the-art cancer treatment to areas distant from cancer centers and research-oriented medical centers. Examined in this evaluation of the second phase of the CCOP are the ability of the 52 currently funded CCOPs and 17 research bases to accrue patients to cancer treatment and cancer control research protocols, their influence on the patterns of practice for cancer treatment in CCOP communities, and their influence on cancer control awareness and activity among primary care physicians. The evaluation applies selected organizational perspectives to describe the intraorganizational and interorganizational characteristics of the CCOPs, research bases, and the Institute that may affect the performance of the CCOP. This organizational approach relates the accrual and influence of the CCOP to controllable aspects of the program's design and management strategies that can be changed through policies directed by the National Cancer Institute. These policies include the criteria used to select CCOPs, the role of research bases in the development and implementation of treatment and cancer control research protocols, and the use of accrual credits.

Entities:  

Mesh:

Year:  1989        PMID: 2681795     DOI: 10.1093/jnci/81.22.1717

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Community cancer programs as strategic alliances: challenges and guidelines for action.

Authors:  A D Kaluzny
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

2.  The role of thematic evaluation in program assessment: the case of the Community Clinical Oncology Program.

Authors:  D Gillings; T C Ricketts; J M Barnsley; A D Kaluzny; L Ford; R Warnecke; E Sondik
Journal:  J Med Syst       Date:  1990-08       Impact factor: 4.460

3.  Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.

Authors:  J E Veney; W P Kory; J M Barnsley; A D Kaluzny
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

4.  Evaluating productivity in clinical research programs: the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP).

Authors:  D M Hynes; C P McLaughlin; A D Kaluzny; L P Ford; E Sondik
Journal:  J Med Syst       Date:  1992-12       Impact factor: 4.460

5.  Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.

Authors:  William R Carpenter; Alice K Fortune-Greeley; Leah L Zullig; Shoou-Yih Lee; Bryan J Weiner
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

Review 6.  Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Authors:  Lori M Minasian; William R Carpenter; Bryan J Weiner; Darrell E Anderson; Worta McCaskill-Stevens; Stefanie Nelson; Cynthia Whitman; Joseph Kelaghan; Ann M O'Mara; Arnold D Kaluzny
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

7.  Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.

Authors:  Bryan J Weiner; Sara R Jacobs; Lori M Minasian; Marjorie J Good
Journal:  J Oncol Pract       Date:  2012-05-01       Impact factor: 3.840

8.  Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.

Authors:  C N Klabunde; A D Kaluzny
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

9.  Ecological analysis of the first generation of community clinical oncology programs.

Authors:  J H Schopler
Journal:  Health Serv Res       Date:  1993-04       Impact factor: 3.402

10.  Determinants of need and unmet need among cancer patients residing at home.

Authors:  V Mor; S M Allen; K Siegel; P Houts
Journal:  Health Serv Res       Date:  1992-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.